Elevar Drug Patent Portfolio
Elevar owns 1 orange book drug protected by 2 US patents Given below is the list of Elevar's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12152034 | Fgfr Inhibitors And Methods Of Making And Using The Same | 18 Nov, 2041 | Active |
| US11780845 | Fgfr Inhibitors And Methods Of Use Thereof | 12 May, 2040 | Active |
Elevar's Family Patents
Elevar Drug List
Given below is the complete list of Elevar's drugs and the patents protecting them.
1. Lyrfigtu
Lyrfigtu is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12152034 | Fgfr Inhibitors And Methods Of Making And Using The Same |
18 Nov, 2041
(15 years from now)
| Active |
| US11780845 | Fgfr Inhibitors And Methods Of Use Thereof |
12 May, 2040
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Lyrfigtu's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List